HMOX1 and Hyperglycemia: Further investigation showed that either Nrf2 overexpression or Nrf2 activator DMF treatment (Zhu et al., 2018) restores hyperglycemia-induced oxidative stress with up-regulated NQO1 and HO1 as well as decreased secretion of inflammatory cytokines.